Apollo Peptide Sciences Review (2026): The Bureau Scorecard

Who Apollo is

Apollo Peptide Sciences is a US research-peptide vendor with a curated, documentation-first catalog concentrated on GLP-1 compounds: semaglutide, tirzepatide, and retatrutide (listed as GLP-3R). Rather than stocking every compound in the niche, Apollo runs a tighter list and attaches real testing documentation to it. That positioning is exactly what it advertises, and in our time ordering from and tracking the vendor, the experience has been consistent with it.

Documentation and COAs

This is where Apollo earns its score. The site publishes third-party HPLC/MS testing references, and batch-level Certificates of Analysis are accessible to customers rather than gated behind support tickets. On a category where a meaningful share of vials sold by unverified vendors are underdosed or degraded, accessible batch documentation is the single most important thing a vendor can offer. Apollo is the only vendor on our scorecard to take a perfect 25/25 on COA transparency.

Ordering and shipping

Domestic shipping on our orders was prompt, with tracking updates that matched reality. Support replied to documentation questions inside the same business day — the fastest response cadence of the six vendors we track. Checkout is standard card processing.

Pricing

The honest trade-off. Apollo's per-vial pricing sits at the top of the category — typically noticeably above Pantheon or Amino Club for equivalent compounds. If you are running an extended protocol on a tight budget, the difference compounds. Our take: for GLP-1 compounds, where underdosing is common and dose accuracy matters most, the documentation premium is worth paying. For cheap, well-understood compounds like BPC-157, a mid-tier vendor is a defensible choice.

Is Apollo Peptide Sciences legit?

Based on our ordering experience and everything observable publicly: yes. Orders arrived as described, documentation matched labels, and the public testing references check out against the batches we received. The main caveat is track record length — Apollo is newer than legacy vendors, so it has fewer years of reputation behind it. Nothing we have seen suggests anything other than a documentation-first operation, and it holds our top score of 4.8/5.

Who should buy here

Researchers prioritizing GLP-1 compounds (semaglutide, tirzepatide, retatrutide) where dose accuracy is critical; anyone who wants batch-level COAs without asking; buyers who value same-day support. Budget-first buyers running simple recovery protocols may prefer Pantheon — see the full comparison on the scorecard.

Score breakdown

Scoring methodology: real orders, documentation verification against published COAs, support-response tracking, and public-reputation cross-checks. Full criteria on the methodology page. No vendor has ever paid for placement or score.